Home » Topics » BioWorld Science

BioWorld Science
RSS

SARS-CoV-2 neutralizing antibody JS-016 begins phase I study in China

June 8, 2020

New arginase inhibitors presented by Arcus Biosciences

June 8, 2020

Sleep deprivation kills through punch to the gut

June 8, 2020

Inception IBD discloses new VNN1 inhibitors

June 8, 2020

Qilu Regor Therapeutics identifies GLP-1 receptor agonists

June 8, 2020

TES Pharma describes ACMSD inhibitors

June 8, 2020

BeiGene patents new MAP4K1 inhibitors

June 8, 2020

Survival improved with apatinib in Chinese patients with pretreated hepatocellular carcinoma

June 8, 2020

Phase I data presented for anti-EGFR ADC MRG-003 in relapsed/refractory solid tumors

June 8, 2020

Series B financing extension to support Artax's development of AX-158 for autoimmune diseases

June 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...